These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9300661)

  • 101. Genetics of Multiple Sclerosis: An Overview and New Directions.
    Patsopoulos NA
    Cold Spring Harb Perspect Med; 2018 Jul; 8(7):. PubMed ID: 29440325
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Association of interleukin 7 receptor gene polymorphism rs6897932 with multiple sclerosis patients in Khuzestan.
    Majdinasab N; Hosseini Behbahani M; Galehdari H; Mohaghegh M
    Iran J Neurol; 2014 Jul; 13(3):168-71. PubMed ID: 25422737
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Absence of IFN-γ increases brain pathology in experimental autoimmune encephalomyelitis-susceptible DRB1*0301.DQ8 HLA transgenic mice through secretion of proinflammatory cytokine IL-17 and induction of pathogenic monocytes/microglia into the central nervous system.
    Mangalam AK; Luo N; Luckey D; Papke L; Hubbard A; Wussow A; Smart M; Giri S; Rodriguez M; David C
    J Immunol; 2014 Nov; 193(10):4859-70. PubMed ID: 25339670
    [TBL] [Abstract][Full Text] [Related]  

  • 104. IL-7R α polymorphisms in 60 Iranian multiple sclerosis patients.
    Raji MA; Khosravi A; Sanati MH; Nabavi SM; Hajihoseini R; Ebrahimi A; Sabour MH
    Iran J Neurol; 2012; 11(1):6-11. PubMed ID: 24250851
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Can we prevent or treat multiple sclerosis by individualised vitamin D supply?
    Dörr J; Döring A; Paul F
    EPMA J; 2013 Jan; 4(1):4. PubMed ID: 23356351
    [TBL] [Abstract][Full Text] [Related]  

  • 106. FTY720 in multiple sclerosis: the emerging evidence of its therapeutic value.
    Thomson A
    Core Evid; 2006; 1(3):157-67. PubMed ID: 22500151
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Role of HLA class II genes in susceptibility and resistance to multiple sclerosis: studies using HLA transgenic mice.
    Luckey D; Bastakoty D; Mangalam AK
    J Autoimmun; 2011 Sep; 37(2):122-8. PubMed ID: 21632210
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Characterization of the major histocompatibility complex class II DOB, DPB1, and DQB1 alleles in cynomolgus macaques of Vietnamese origin.
    Ling F; Wei LQ; Wang T; Wang HB; Zhuo M; Du HL; Wang JF; Wang XN
    Immunogenetics; 2011 Mar; 63(3):155-66. PubMed ID: 21132285
    [TBL] [Abstract][Full Text] [Related]  

  • 109. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.
    Mangalam A; Luckey D; Basal E; Jackson M; Smart M; Rodriguez M; David C
    J Immunol; 2009 Apr; 182(8):5131-9. PubMed ID: 19342694
    [TBL] [Abstract][Full Text] [Related]  

  • 110. The IFN-gamma-induced transcriptional program of the CIITA gene is inhibited by statins.
    Lee SJ; Qin H; Benveniste EN
    Eur J Immunol; 2008 Aug; 38(8):2325-36. PubMed ID: 18601229
    [TBL] [Abstract][Full Text] [Related]  

  • 111. HLA-DQ6 (DQB1*0601)-restricted T cells protect against experimental autoimmune encephalomyelitis in HLA-DR3.DQ6 double-transgenic mice by generating anti-inflammatory IFN-gamma.
    Mangalam A; Luckey D; Basal E; Behrens M; Rodriguez M; David C
    J Immunol; 2008 Jun; 180(11):7747-56. PubMed ID: 18490779
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Genetic analysis of the exon 1 position 49 CD152 dimorphism in multiple sclerosis.
    Stuart R; Lovett-Racke AE; Frohman EM; Hawker K; Racke MK
    J Neuroimmunol; 2007 Nov; 191(1-2):45-50. PubMed ID: 17920697
    [TBL] [Abstract][Full Text] [Related]  

  • 113. A dinucleotide deletion in CD24 confers protection against autoimmune diseases.
    Wang L; Lin S; Rammohan KW; Liu Z; Liu JQ; Liu RH; Guinther N; Lima J; Zhou Q; Wang T; Zheng X; Birmingham DJ; Rovin BH; Hebert LA; Wu Y; Lynn DJ; Cooke G; Yu CY; Zheng P; Liu Y
    PLoS Genet; 2007 Apr; 3(4):e49. PubMed ID: 17411341
    [TBL] [Abstract][Full Text] [Related]  

  • 114. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians.
    Bugeja MJ; Booth D; Bennetts B; Heard R; Rubio J; Stewart G
    BMC Med Genet; 2006 Jul; 7():64. PubMed ID: 16872505
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Pediatric multiple sclerosis.
    Banwell BL
    Curr Neurol Neurosci Rep; 2004 May; 4(3):245-52. PubMed ID: 15102351
    [TBL] [Abstract][Full Text] [Related]  

  • 116. New approaches to investigating heterogeneity in complex traits.
    Bomprezzi R; Kovanen PE; Martin R
    J Med Genet; 2003 Aug; 40(8):553-9. PubMed ID: 12920061
    [TBL] [Abstract][Full Text] [Related]  

  • 117. Interleukin (IL)-1 gene polymorphisms: relevance of disease severity associated alleles with IL-1beta and IL-1ra production in multiple sclerosis.
    Schrijver HM; van As J; Crusius JB; Dijkstra CD; Uitdehaag BM
    Mediators Inflamm; 2003 Apr; 12(2):89-94. PubMed ID: 12775358
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis.
    Höllsberg P; Hansen HJ; Haahr S
    Clin Exp Immunol; 2003 Apr; 132(1):137-43. PubMed ID: 12653848
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Magnetisation transfer ratio analysis of normal appearing white matter in patients with familial and sporadic multiple sclerosis.
    Siger-Zajdel M; Selmaj K
    J Neurol Neurosurg Psychiatry; 2001 Dec; 71(6):752-6. PubMed ID: 11723195
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
    Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
    Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.